Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

PET

  • You have access
    18F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
    WONSEOK WHI, HYUNJONG LEE, JUNG YONG HONG, WONSEOK KANG, YOUNG SEOK CHO, SEUNG HWAN MOON, JOON YOUNG CHOI, KYUNG-HAN LEE and SEUNG HYUP HYUN
    Anticancer Research March 2025, 45 (3) 1273-1280; DOI: https://doi.org/10.21873/anticanres.17514
  • Open Access
    [11C]Methionine PET vs. [18F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients
    MOTOKAZU SATO, TOSHIHIKO SATO, CHIHIRO HOZUMI, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN
    Anticancer Research September 2024, 44 (9) 3891-3898; DOI: https://doi.org/10.21873/anticanres.17216
  • You have access
    Effect of Epidermal Growth Factor Receptor Mutation on Positron Emission Tomography/Computed Tomography in Lung Cancer
    JI SUN PARK, HA YOUNG PARK and YUNSEON CHOI
    Anticancer Research June 2024, 44 (6) 2681-2687; DOI: https://doi.org/10.21873/anticanres.17075
  • You have access
    Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery
    YOICHI HAMAI, MANABU EMI, YUTA IBUKI, TOMOAKI KUROKAWA, TORU YOSHIKAWA, MANATO OHSAWA, RYOSUKE HIROHATA, NAO KITASAKI and MORIHITO OKADA
    Anticancer Research December 2022, 42 (12) 6037-6045; DOI: https://doi.org/10.21873/anticanres.16115
  • You have access
    Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer
    SHINSUKE SASADA, YURI KIMURA, AKIKO EMI, NORIO MASUMOTO, TAKAYUKI KADOYA, KOJI ARIHIRO and MORIHITO OKADA
    Anticancer Research June 2020, 40 (6) 3395-3400; DOI: https://doi.org/10.21873/anticanres.14323
  • You have access
    Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT
    THOMAS SELIM NAKUZ, FILIPE PORTELA MILLINGER, KAREM EL-RABADI, MICHAEL WEBER, VERENA PICHLER, WOLFGANG WADSAK, MARKUS MITTERHAUSER, ALEXANDER HAUG, MARCUS HACKER, GEORGIOS KARANIKAS, PETER PIETSCHMANN and HERMINE AGIS
    Anticancer Research April 2019, 39 (4) 1943-1952; DOI: https://doi.org/10.21873/anticanres.13304
  • You have access
    Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma?
    TOMOHITO HAGI, TOMOKI NAKAMURA, YUICHI SUGINO, TAKAO MATSUBARA, KUNIHIRO ASANUMA and AKIHIRO SUDO
    Anticancer Research June 2018, 38 (6) 3635-3639; DOI: https://doi.org/10.21873/anticanres.12638
  • You have access
    Associations Between Histogram Analysis DCE MRI Parameters and Complex 18F-FDG-PET Values in Head and Neck Squamous Cell Carcinoma
    ALEXEY SUROV, LEONARD LEIFELS, HANS JONAS MEYER, KARSTEN WINTER, OSAMA SABRI and SANDRA PURZ
    Anticancer Research March 2018, 38 (3) 1637-1642;
  • You have access
    Clinical Value of 18F-FDOPA PET/CT With Contrast Enhancement and Without Carbidopa Premedication in Patients with Insulinoma
    THOMAS SELIM NAKUZ, ERIK BERGER, KAREM EL-RABADI, WOLFGANG WADSAK, ALEXANDER HAUG, MARCUS HACKER and GEORGIOS KARANIKAS
    Anticancer Research January 2018, 38 (1) 353-358;
  • You have access
    Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer
    JEON YEOB JANG, KYOUNG JUNE PAK, KEUN-IK YI, YONG KAN KI, WON TAEK KIM, HYOJEONG KIM, YOUNG JIN CHOI, SEONG JANG KIM, IN JOO KIM, SOO-GEUN WANG and YOUNG MI SEOL
    Anticancer Research October 2017, 37 (10) 5899-5905;

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire